1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. KINDLY MD INC.
Kindly MD Inc.
XNAS: NAKA
Download real time
0.20 0.01 (5.26%)
New 52W Low in past week
906.3K
XNAS Volume

XNAS 05 May, 2026 10:33 AM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Kindly MD Inc

The latest disclosure was made by Tyler Matthew Evans in Kindly MD Inc where a trade of 600,000 Common Stock done was reported to US exchanges on March 12, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2026 600,000 20,852,678 - 0 Common Stock
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 3,596,392 25,421,822 - - Stock Option
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 2,470,803 25,421,822 - - Stock Option
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 17,841,993 20,252,858 - 0 Common Stock
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 4,118,006 25,421,822 - - Stock Option
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 12,491,284 25,421,822 - - Stock Option
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 3,596,392 25,421,822 - - Stock Option
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 2,745,337 25,421,822 - - Stock Option
Andrew John Creighton Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 1,685,500 1,685,500 - - Stock Option
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 17,841,993 20,252,678 - 0 Common Stock
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 4,118,006 25,421,822 - - Stock Option
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 2,470,803 25,421,822 - - Stock Option
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 2,745,337 25,421,822 - - Stock Option
Tyler Matthew Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2026 12,491,284 25,421,822 - - Stock Option
John Dalton Chief Accounting Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2025 1,574,803 1,574,803 - 0 Common Stock
Teresa S. Gendron Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Dec 2025 2,624,671 2,624,671 - 0 Common Stock
Tyler Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 601,503 3,012,188 - 0 Common Stock
Amanda Fabiano Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 3,383,458 4,135,337 - 0 Common Stock
Amanda Fabiano Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 751,879 751,879 - 0 Common Stock
Andrew John Creighton Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 601,503 3,726,474 - 0 Common Stock
Charles P. Blackburn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 112,781 112,781 - 0 Common Stock
Perianne Boring McNulty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 112,781 112,781 - 0 Common Stock
Gregory Elias Xethalis Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 112,781 112,781 - 0 Common Stock
Mark W. Yusko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 112,781 2,212,781 - 0 Common Stock
Jared Barrera Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Sep 2025 6,400 22,242 - 0 Common Stock
Timothy Pickett Director, Chief Medical Officer 22 Sep 2025 26,129 162,747 - 0 Common Stock
Timothy Pickett Director, Chief Medical Officer 22 Sep 2025 10,146 172,893 - 0 Common Stock
Timothy Pickett Director, Chief Medical Officer 22 Sep 2025 18,378 191,271 - 0 Common Stock
Timothy Pickett Director, Chief Medical Officer 22 Sep 2025 37,593 136,618 - 0 Common Stock
Tyler Evans Chief Investment Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2025 2,232,114 2,410,685 - 0 Common Stock
Andrew John Creighton Chief Compliance Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Aug 2025 2,232,114 3,124,971 - 0 Common Stock
Amy Powell Director Grant, award, or other acquisition of securities at price $ 1.61 per share. 12 May 2025 1,838 5,114 - 1.6 2,959 Common Stock
Christian Robinson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2025 2,000 3,387 - - Option
Christian Robinson Director Grant, award, or other acquisition of securities at price $ 1.61 per share. 12 May 2025 1,838 5,114 - 1.6 2,959 Common Stock
Christian Robinson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2025 538 3,925 - - Option
Timothy Pickett Director, CEO, Ten Percent Owner 12 May 2025 28,780 99,025 - 1.6 46,336 Common Stock
Timothy Pickett Director, CEO, Ten Percent Owner 12 May 2025 7,479 53,823 - - Option
Adam Cox Director, COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2025 40,000 56,304 - - Option
Jared Barrera CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2025 35,000 53,147 - - Option
Amy Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2025 2,000 3,387 - - Option
Amy Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2025 538 3,925 - - Option
Gary Seelhorst Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2025 2,000 3,387 - - Option
Gary Seelhorst Director Grant, award, or other acquisition of securities at price $ 1.61 per share. 12 May 2025 1,838 5,114 - 1.6 2,959 Common Stock
Gary Seelhorst Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 May 2025 538 3,925 - - Option
Christian Robinson Director 28 Oct 2024 837 837 - 1.1 879 Common Stock
Amy Powell Director 28 Oct 2024 837 837 - 1.1 879 Common Stock
Gary Seelhorst Director 28 Oct 2024 837 837 - 1.1 879 Common Stock
Adam Cox Director, COO 28 Oct 2024 9,000 72,834 - 1.1 9,450 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters